Sea Limited (NYSE:SE ) Q2 2025 Earnings Call August 12, 2025 7:30 AM ET Company Participants Tony Tianyu Hou - Chief Financial Officer Xiaodong Li - Founder, Chairman & CEO Conference Call Participants Alicia Yap - Citigroup Inc., Research Division Divya Gangahar Kothiyal - Morgan Stanley, Research Division Hyungwook Choi - Daiwa Securities Co. Ltd., Research Division Jiong Shao - Barclays Bank PLC, Research Division Pang Vittayaamnuaykoon - Goldman Sachs Group, Inc., Research Division Piyush Choudhary - HSBC Global Investment Research Thomas Chong - Jefferies LLC, Research Division Operator [indiscernible] to all, and welcome to the Sea Limited Second Quarter …

The chip maker could ask for more monetary support and for the White House to encourage customers to use its advanced chips, Bernstein analysts said.

The gig economy presents numerous benefits, and for those looking to capitalize on this growing trend, keeping an eye on stocks such as UBER, DASH and AMZN could be a wise move.

The Goldman Sachs Group, Inc. GS enjoys a strong balance sheet position. As of June 30, 2025, cash and cash equivalents were $153 billion.

Adam Aron, AMC Entertainment CEO, joins CNBC's 'Squawk on the Street' to discuss the company's recent earnings, movie pipeline, and much more.

Orla Mining Ltd. (NYSE:ORLA ) Q2 2025 Earnings Conference Call August 12, 2025 10:31 AM ET Company Participants Andrew Bradbury - Vice President of Corporate Development & Investor Relations Andrew Cormier - Corporate Participant Etienne Morin - Chief Financial Officer Jason Douglas Simpson - President, CEO & Director Silvana Costa - Chief Sustainability Officer Sylvain Guerard - Senior Vice President of Exploration Conference Call Participants Wayne Lam - TD Cowen, Research Division Operator Good morning, ladies and gentlemen, and welcome to the Orla Mining's Conference Call for the Second Quarter 2025 results.

BigBear.ai is the latest software stock to stumble but Micron Technology is a reminder that the hardware side of the AI boom is still robust.

YORK, Pa., Aug. 12, 2025 (GLOBE NEWSWIRE) -- The York Water Company's (NASDAQ:YORW) President, JT Hand, announced the Company's financial results for the second quarter and the first six months of 2025.

Primoris sees strong infrastructure demand driving growth in 2025, fueled by renewables, utilities and energy projects.

Try the GARP strategy when seeking a profitable portfolio of stocks offering optimum value and growth investing. RL, SYK, RGLD and ADSK hold promise.

I rate PBW a hold due to its high volatility, small cap focus, and lackluster long-term returns despite strong clean energy tailwinds. The ETF offers exposure to innovative clean energy trends—especially batteries and grid optimization—but its small cap tilt increases risk and requires careful entry timing. PBW's expense ratio is high, most holdings are unprofitable, and its dividend is value-destructive; I recommend waiting for a lower P/B ratio before buying.

SEATTLE--(BUSINESS WIRE)-- #AI--Massed Compute, an AI cloud providing GPU clusters, announces up to $300M investment from Digital Alpha and strategic collaboration with Cisco.

Royalty Management Holding Corp (NASDAQ:RMCO) is taking a broader view of the royalty business. While many peers concentrate on a single commodity, the Indiana-based firm is building a portfolio that spans critical minerals, sustainable land use, advanced manufacturing and even Bitcoin.

Smithfield Foods, Inc. (NASDAQ:SFD ) Q2 2025 Earnings Conference Call August 12, 2025 9:00 AM ET Company Participants C. Shane Smith - President, CEO & Director Julie MacMedan - Vice President of Investor Relations Mark L.

The U.S. Food and Drug Administration has approved Insmed's oral drug for a type of lung disease, the company said on Tuesday, making it the first treatment for the chronic condition.

ChipMOS TECHNOLOGIES INC. (NASDAQ:IMOS ) Q2 2025 Earnings Conference Call August 12, 2025 3:00 AM ET Company Participants G.

Circle Internet Group (CRCL) shares jumped nearly 8% Tuesday as its first financial report since its initial public offering (IPO) came in better than expected on growing use of the USDC stablecoin.

Clorox is just shy of the Dividend King title, awarded to companies with 50 years of consecutive dividend increases. The robust portfolio of consumer durables reliably supports dividend growth through all market environments. I rate Clorox a Hold and recommend waiting for a $100 entry point, which would offer a 5% yield and a margin of safety.

Cardinal Health's fourth-quarter fiscal 2025 results benefit from solid Medical and Other segments' revenue growth. However, OptumRx contract expiry hurts Pharmaceutical segment sales.

Will GS's strategic shifts, M&A rebound and strong capital returns boost growth prospects? Let us find out.